- Home
- EXEL vs BILI Comparison
EXEL vs BILI Comparison
Compare EXEL & BILI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EXEL | BILI |
|---|---|---|
| Founded | 1994 | 2009 |
| Country | United States | China |
| Employees | N/A | 8088 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.4B | 9.3B |
| IPO Year | 2000 | N/A |
Fundamental Metrics
Financial Performance| Metric | EXEL | BILI |
|---|---|---|
| Price | $44.47 | $22.00 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 21 | 8 |
| Target Price | ★ $46.50 | $31.13 |
| AVG Volume (30 Days) | ★ 2.1M | 1.9M |
| Earning Date | 05-05-2026 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 57.95 | N/A |
| EPS | ★ 2.78 | N/A |
| Revenue | ★ $452,477,000.00 | N/A |
| Revenue This Year | $13.61 | $11.77 |
| Revenue Next Year | $13.13 | $9.59 |
| P/E Ratio | ★ $16.05 | $122.37 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $33.76 | $17.46 |
| 52 Week High | $48.74 | $36.40 |
Technical Indicators
Market Signals| Indicator | EXEL | BILI |
|---|---|---|
| Relative Strength Index (RSI) | 50.94 | 37.74 |
| Support Level | $40.98 | $21.84 |
| Resistance Level | $46.66 | $25.65 |
| Average True Range (ATR) | 1.37 | 0.61 |
| MACD | -0.13 | -0.15 |
| Stochastic Oscillator | 23.86 | 22.24 |
Price Performance
Historical ComparisonAbout EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About BILI Bilibili Inc.
Bilibili is a Chinese online entertainment platform best known for its YouTube-like video-sharing service. Founded in 2009, it initially focused on long-form content centered around anime, comics, and gaming, or ACG, catering primarily to Generation Z users. Over time, the platform has expanded its content ecosystem to cover a broader range of interests, successfully attracting a more diverse audience beyond its original Gen Z base.